Bone events and evolution of biologic markers in Gaucher disease before and during treatment.

Abstract : INTRODUCTION : Known biomarkers of Gaucher-disease activity are platelets, chitotriosidase, angiotensin-converting enzyme (ACE), tartrate-resistant acid phosphatase (TRAP) and ferritin. The aim of this study was to retrospectively evaluate the frequency of bone events (BE) and biomarker changes during two periods: diagnosis to first enzyme-replacement therapy (ERT) and the latter to the closing date. METHODS : BE of 62 treated patients, among the 73-patient cohort followed at Beaujon Hospital, Clichy, France, were described with Kaplan-Meier curves, and linear-mixed models were used to analyze their biomarker changes and the influence of several covariates (splenectomy, diagnosis year, genotype, age at diagnosis and sex). RESULTS : BE occurred before (54 events in 21 patients), but also during, ERT (12 events in 10 patients), with respective frequencies (95% confidence interval) at 10 years of 22.4% (13.3 to 36.3) and 20.0% (10.2 to 36.9). Biomarker slope changes before and during ERT differed significantly for platelets (+190/mm3/year and 7,035/mm3/year, respectively; P < 0.0001) and ferritin (+4% and -14%; P < 0.0001). High ferritin levels and low platelet counts at ERT onset were significantly associated with BE during ERT (P = 0.019 and 0.039, respectively). Covariates significantly influenced biomarker changes (baseline and/or slope): splenectomy affected platelets (baseline and changes), TRAP changes and chitotriosidase changes; diagnosis date influenced ACE and TRAP baseline values; and genotype influenced chitotriosidase baseline and changes. CONCLUSIONS : Platelet counts and ferritin levels and their slope changes at ERT onset seem to predict BE during treatment. Biomarker baseline values and changes are dependent on several covariables.
Type de document :
Article dans une revue
Arthritis Research and Therapy, BioMed Central, 2010, 12 (4), pp.R156. 〈10.1186/ar3111〉
Liste complète des métadonnées

Littérature citée [29 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00544232
Contributeur : Thu Thuy Nguyen <>
Soumis le : mardi 7 décembre 2010 - 15:15:15
Dernière modification le : mercredi 29 novembre 2017 - 16:47:53
Document(s) archivé(s) le : lundi 5 novembre 2012 - 12:31:24

Fichier

ar3111.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Jérôme Stirnemann, Nadia Belmatoug, Corine Vincent, Olivier Fain, Bruno Fantin, et al.. Bone events and evolution of biologic markers in Gaucher disease before and during treatment.. Arthritis Research and Therapy, BioMed Central, 2010, 12 (4), pp.R156. 〈10.1186/ar3111〉. 〈inserm-00544232〉

Partager

Métriques

Consultations de la notice

287

Téléchargements de fichiers

82